Diagnosis of opportunistic infections in non-small cell lung cancer

V. Aginova, Z. V. Grigoryevskaya, N. Karazhas, I. N. Petukhova, N. L. Pul’nova, T. N. Rybalkina, L. A. Nelubina, N. S. Bagirova, L. V. Cherkes, R. E. Bosh’yan, M. Kornienko, I. V. Tereshchenko, V. V. Breder, K. Laktionov
{"title":"Diagnosis of opportunistic infections in non-small cell lung cancer","authors":"V. Aginova, Z. V. Grigoryevskaya, N. Karazhas, I. N. Petukhova, N. L. Pul’nova, T. N. Rybalkina, L. A. Nelubina, N. S. Bagirova, L. V. Cherkes, R. E. Bosh’yan, M. Kornienko, I. V. Tereshchenko, V. V. Breder, K. Laktionov","doi":"10.17650/2949-5857-2024-14-2-54-62","DOIUrl":null,"url":null,"abstract":"Aim. To investigate the species composition and frequency of opportunistic pathogens in cancer patients diagnosed with non-small cell lung cancer (NSCLC) receiving chemotherapeutic treatment at the Federal State Budgetary Institution National Medical Research Center of Oncology named after N. N. Blokhin of the Russian Ministry of Health.Materials and methods. A prospective open single-center study included a cohort of patients with locally advanced or metastatic NSCLC receiving drug antitumor therapy, aged 18 years and older. The study was observational in nature. The endpoint of this phase of the study was to determine the relative number of NSCLC patients with chronic infection (pneumocystis, herpes simplex virus (HSV) 1, HSV-2, cytomegalovirus (CMV), Epstein–Barr virus (EBV), human herpes virus type 6 (HHV-6) and their combinations).Results. Antibodies to herpes viruses and/or pneumocystis were detected in patients (n = 18) diagnosed with NSCLC in 100 % of cases. Antibody titers corresponding to active infection were more characteristic for EBV and CMV, with CMV infection markers more often registered in titers corresponding to the acute stage of the disease, and EBV – in the reactivation stage without obvious clinical manifestations. In most cases, mixed infection with different pathogens was determined: combination of HSV-1 + EBV + CMV was found in 55.5 % (n = 10) of NSCLC patients; HSV-1 + EBV + CMV + HHV-6 – in 33.3 % (n = 6) of cases, HSV-1 + HSV-2 + EBV + CMV – in 5.5 % (n = 1), HSV-1 + HSV-2 + EBV + CMV + HHV-6 also in 5.5 % (n = 1) of patients. During bronchoalveolar lavage examination, pneumocystis were detected in 3 (42.8 %) out of 7 examined patients.Conclusion. Based on the results of studies of a relatively small cohort of patients in the absence of clinical symptoms of infection in NSCLC patients, a high percentage of IgM and IgG antibodies, which are markers of opportunistic infections and their combinations, were detected. Pneumocystis was isolated from bronchoalveolar lavage in 42.8 % of cases. It is necessary to evaluate the results obtained in a larger number of patients to determine approaches to the prevention and treatment of opportunistic infections.","PeriodicalId":509681,"journal":{"name":"Surgery and Oncology","volume":" 18","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2949-5857-2024-14-2-54-62","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim. To investigate the species composition and frequency of opportunistic pathogens in cancer patients diagnosed with non-small cell lung cancer (NSCLC) receiving chemotherapeutic treatment at the Federal State Budgetary Institution National Medical Research Center of Oncology named after N. N. Blokhin of the Russian Ministry of Health.Materials and methods. A prospective open single-center study included a cohort of patients with locally advanced or metastatic NSCLC receiving drug antitumor therapy, aged 18 years and older. The study was observational in nature. The endpoint of this phase of the study was to determine the relative number of NSCLC patients with chronic infection (pneumocystis, herpes simplex virus (HSV) 1, HSV-2, cytomegalovirus (CMV), Epstein–Barr virus (EBV), human herpes virus type 6 (HHV-6) and their combinations).Results. Antibodies to herpes viruses and/or pneumocystis were detected in patients (n = 18) diagnosed with NSCLC in 100 % of cases. Antibody titers corresponding to active infection were more characteristic for EBV and CMV, with CMV infection markers more often registered in titers corresponding to the acute stage of the disease, and EBV – in the reactivation stage without obvious clinical manifestations. In most cases, mixed infection with different pathogens was determined: combination of HSV-1 + EBV + CMV was found in 55.5 % (n = 10) of NSCLC patients; HSV-1 + EBV + CMV + HHV-6 – in 33.3 % (n = 6) of cases, HSV-1 + HSV-2 + EBV + CMV – in 5.5 % (n = 1), HSV-1 + HSV-2 + EBV + CMV + HHV-6 also in 5.5 % (n = 1) of patients. During bronchoalveolar lavage examination, pneumocystis were detected in 3 (42.8 %) out of 7 examined patients.Conclusion. Based on the results of studies of a relatively small cohort of patients in the absence of clinical symptoms of infection in NSCLC patients, a high percentage of IgM and IgG antibodies, which are markers of opportunistic infections and their combinations, were detected. Pneumocystis was isolated from bronchoalveolar lavage in 42.8 % of cases. It is necessary to evaluate the results obtained in a larger number of patients to determine approaches to the prevention and treatment of opportunistic infections.
非小细胞肺癌机会性感染的诊断
目的调查在以俄罗斯卫生部 N. N. Blokhin 命名的联邦国家预算机构国家肿瘤医学研究中心接受化疗的非小细胞肺癌(NSCLC)癌症患者中机会性病原体的种类组成和频率。布洛欣命名的联邦国家预算机构国家肿瘤医学研究中心接受化疗的非小细胞肺癌(NSCLC)病原体。这是一项前瞻性开放式单中心研究,研究对象包括接受药物抗肿瘤治疗的局部晚期或转移性 NSCLC 患者,年龄在 18 岁及以上。该研究为观察性研究。本阶段研究的终点是确定慢性感染(肺孢子虫、单纯疱疹病毒(HSV)1、HSV-2、巨细胞病毒(CMV)、爱泼斯坦-巴氏病毒(EBV)、人类疱疹病毒 6 型(HHV-6)及其组合)的 NSCLC 患者的相对数量。在确诊为 NSCLC 的患者(n = 18)中,100% 的病例都检测到了疱疹病毒和/或肺孢子虫抗体。与活动性感染相对应的抗体滴度是 EBV 和 CMV 的特征,CMV 感染标记物的滴度通常与疾病的急性期相对应,而 EBV 则与无明显临床表现的再活化期相对应。在大多数病例中,确定了不同病原体的混合感染:55.5%(n = 10)的 NSCLC 患者合并有 HSV-1 + EBV + CMV;33.3%(n = 6)的病例合并有 HSV-1 + EBV + CMV + HHV-6;5.5%(n = 1)的病例合并有 HSV-1 + HSV-2 + EBV + CMV + CMV;5.5%(n = 1)的患者合并有 HSV-1 + HSV-2 + EBV + CMV + HHV-6。在支气管肺泡灌洗检查中,7 名受检患者中有 3 人(42.8%)发现了肺孢子虫。根据对相对较少的 NSCLC 患者群的研究结果,在没有感染临床症状的情况下,检测到了较高比例的 IgM 和 IgG 抗体,这些抗体是机会性感染及其合并感染的标志。42.8%的病例从支气管肺泡灌洗液中分离出肺囊虫。有必要对更多患者的结果进行评估,以确定预防和治疗机会性感染的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信